These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 29464583)

  • 1. Intestinal Involvement in Systemic Sclerosis: A Clinical Review.
    Sakkas LI; Simopoulou T; Daoussis D; Liossis SN; Potamianos S
    Dig Dis Sci; 2018 Apr; 63(4):834-844. PubMed ID: 29464583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nutrition in systemic sclerosis.
    Recasens MA; Puig C; Ortiz-Santamaria V
    Reumatol Clin; 2012; 8(3):135-40. PubMed ID: 22197834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal calprotectin in systemic sclerosis and review of the literature.
    Marie I; Leroi AM; Menard JF; Levesque H; Quillard M; Ducrotte P
    Autoimmun Rev; 2015 Jun; 14(6):547-54. PubMed ID: 25661980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical correlates of faecal incontinence in systemic sclerosis: identifying therapeutic avenues.
    Richard N; Hudson M; Gyger G; Baron M; Sutton E; Khalidi N; Pope JE; Carrier N; Larché M; Albert A; Fortin PR; Thorne C; Masetto A;
    Rheumatology (Oxford); 2017 Apr; 56(4):581-588. PubMed ID: 28013205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal manifestations of scleroderma.
    Young MA; Rose S; Reynolds JC
    Rheum Dis Clin North Am; 1996 Nov; 22(4):797-823. PubMed ID: 8923597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrointestinal manifestations of progressive systemic sclerosis.
    Lock G; Holstege A; Lang B; Schölmerich J
    Am J Gastroenterol; 1997 May; 92(5):763-71. PubMed ID: 9149182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small intestinal bacterial overgrowth in systemic sclerosis: a review of the literature.
    Polkowska-Pruszyńska B; Gerkowicz A; Szczepanik-Kułak P; Krasowska D
    Arch Dermatol Res; 2019 Jan; 311(1):1-8. PubMed ID: 30382339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gastrointestinal involvement in systemic sclerosis].
    Marie I
    Presse Med; 2006 Dec; 35(12 Pt 2):1952-65. PubMed ID: 17159722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of Saccharomyces boulardii and Metronidazole for Small Intestinal Bacterial Overgrowth in Systemic Sclerosis.
    García-Collinot G; Madrigal-Santillán EO; Martínez-Bencomo MA; Carranza-Muleiro RA; Jara LJ; Vera-Lastra O; Montes-Cortes DH; Medina G; Cruz-Domínguez MP
    Dig Dis Sci; 2020 Apr; 65(4):1134-1143. PubMed ID: 31549334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and predictors of small intestinal bacterial overgrowth in systemic sclerosis patients with gastrointestinal symptoms.
    Tauber M; Avouac J; Benahmed A; Barbot L; Coustet B; Kahan A; Allanore Y
    Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-82-7. PubMed ID: 25372792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and predictors of small intestinal bacterial overgrowth in systemic sclerosis: a systematic review and meta-analysis.
    Feng X; Li XQ; Jiang Z
    Clin Rheumatol; 2021 Aug; 40(8):3039-3051. PubMed ID: 33426631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Involvement of the small intestine in systemic scleroderma].
    Marie I; Lévesque H; Ducrotté P; Courtois H
    Rev Med Interne; 1999 Jun; 20(6):504-13. PubMed ID: 10422142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pneumatosis cystoides intestinalis in scleroderma-related conditions.
    Balbir-Gurman A; Brook OR; Chermesh I; Braun-Moscovici Y
    Intern Med J; 2012 Mar; 42(3):323-9. PubMed ID: 22432985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic Sclerosis: Gastrointestinal Disease and Its Management.
    Gyger G; Baron M
    Rheum Dis Clin North Am; 2015 Aug; 41(3):459-73. PubMed ID: 26210129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gastrointestinal features in systemic sclerosis].
    Stelle M; Chizzolini C
    Rev Med Suisse; 2014 Apr; 10(426):860-3. PubMed ID: 24834644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal manifestations of systemic sclerosis.
    Domsic R; Fasanella K; Bielefeldt K
    Dig Dis Sci; 2008 May; 53(5):1163-74. PubMed ID: 17934861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small intestinal bacterial overgrowth in systemic sclerosis.
    Marie I; Ducrotté P; Denis P; Menard JF; Levesque H
    Rheumatology (Oxford); 2009 Oct; 48(10):1314-9. PubMed ID: 19696066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small intestinal bacterial overgrowth in patients suffering from scleroderma: clinical effectiveness of its eradication.
    Parodi A; Sessarego M; Greco A; Bazzica M; Filaci G; Setti M; Savarino E; Indiveri F; Savarino V; Ghio M
    Am J Gastroenterol; 2008 May; 103(5):1257-62. PubMed ID: 18422815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrointestinal involvement in systemic sclerosis.
    Savarino E; Furnari M; de Bortoli N; Martinucci I; Bodini G; Ghio M; Savarino V
    Presse Med; 2014 Oct; 43(10 Pt 2):e279-91. PubMed ID: 25179275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What tests should you use to assess small intestinal bacterial overgrowth in systemic sclerosis?
    Braun-Moscovici Y; Braun M; Khanna D; Balbir-Gurman A; Furst DE
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S117-22. PubMed ID: 26339892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.